RNF43 codon 659-mutated combined with non-class 1 BRAF-mutated and MSI-H had the best prognosis, with OS reaching 100% in 13 patients, mainly stage III-IV CRC patients (11/13). This evidence concerns the gene BRAF and colorectal carcinoma.